AG
TWST icon

AmeriFlex Group’s Twist Bioscience TWST Stock Holding History

AmeriFlex Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309 Hold
3
– – ﹤0.01% 1523
2026
Q1 		$143 Hold
3
– – ﹤0.01% 1083
2025
Q4 		$95 Sell
3
-3
-50% -$94 ﹤0.01% 1133
2025
Q3 		$169 Buy
+6
New +$182 ﹤0.01% 1077

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AmeriFlex Group's TWST Position: Q2 2026 in Review

AmeriFlex Group held its Twist Bioscience (TWST) position steady in Q2 2026 at 3 shares worth $309. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

AmeriFlex Group first reported a position in TWST in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • AmeriFlex Group held 3 shares of Twist Bioscience worth $309 as of Q2 2026.
  • AmeriFlex Group left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1523 holding.
  • AmeriFlex Group first reported a position in Twist Bioscience in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.